Airi Põder

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

Himal Lal, Anthony L. Cunningham, Olivier Godeaux et al. · New England Journal of Medicine · 2015 · 1.4K citations · Full text

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

Marta López‐Fauqued, Laura Cámpora, Frédérique Delannois et al. · Vaccine · 2019 · 61 citations · Full text

Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study

Himal Lal, Airi Põder, Laura Cámpora et al. · Vaccine · 2017 · 50 citations · Full text

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial

Céline Maréchal, Himal Lal, Airi Põder et al. · Vaccine · 2018 · 34 citations · Full text

Immunodeficiencies, Immunology, Immunodominance +18

Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials

David O. Willer, Lidia Oostvogels, Anthony L. Cunningham et al. · Vaccine · 2019 · 27 citations · Full text